Yokota R, Tanaka M, Yamasaki K, Araki M, Miyamae M, Maeda T, Koga K, Yabuuchi Y, Sasayama S
Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Int J Cardiol. 1998 Dec 31;67(3):225-36. doi: 10.1016/s0167-5273(98)00257-5.
We investigated if blockade of ATP-sensitive K+ channels (KATP) abolishes the protective effect of ischemic preconditioning (IP) on myocardial metabolism and ischemia-induced reactive hyperemia (RH) in pigs.
IP was elicited by a single cycle of 5 min occlusion and 5 min reperfusion of coronary artery, followed by 15 min of test ischemia and 120 min of reperfusion. Vehicle or the ATP-sensitive K+ channels (KATP) blocker, glibenclamide (3 or 6 mg/kg; G3 or G6) was administered before IP (groups; IP, G3+IP, G6+IP). As respective controls, the same treatment was performed in groups without IP (groups; C, G3, G6). Tissue levels of ATP, creatine phosphate (CP) and intracellular pH (pHi) in the area at risk were measured by 31P-nuclear magnetic resonance spectroscopy. RH after 5 min of preconditioning ischemia was assessed by regional myocardial blood flow.
ATP and pHi were preserved after 15 min of ischemia in the IP group [C/IP; ATP=57+/-4/76+/-10% of baseline, pHi=6.18+/-0.08/6.66+/-0.03, P<0.05, C vs. IP]. Both doses of glibenclamide completely abolished the ATP sparing effect of IP. The high dose completely abolished pHi preservation (G6+IP=6.33+/-0.06), while the low dose showed only a partial effect (G3+IP=6.48+/-0.03). Glibenclamide did not adversely affect myocardial metabolism in groups without IP. Glibenclamide attenuated RH after 5 min of ischemia by 30% in both subendocardium and subepicardium.
Blockade of KATP abolished the preconditioning effect on myocardial metabolism, and partially attenuated post-ischemic reactive hyperemia in pigs. These results indicate that KATP activation might be involved in the mechanisms of these phenomena, reactive hyperemia is not sufficient to induce IP protection.
我们研究了阻断ATP敏感性钾通道(KATP)是否会消除缺血预处理(IP)对猪心肌代谢和缺血诱导的反应性充血(RH)的保护作用。
通过冠状动脉单次5分钟闭塞和5分钟再灌注诱导IP,随后进行15分钟的试验性缺血和120分钟的再灌注。在IP之前给予载体或ATP敏感性钾通道(KATP)阻滞剂格列本脲(3或6mg/kg;G3或G6)(组;IP、G3+IP、G6+IP)。作为各自的对照,在无IP的组中进行相同的处理(组;C、G3、G6)。通过31P-核磁共振波谱法测量危险区域的ATP、磷酸肌酸(CP)组织水平和细胞内pH(pHi)。预处理缺血5分钟后的RH通过局部心肌血流进行评估。
IP组缺血15分钟后ATP和pHi得以保留[C/IP;ATP=基线的57±4/76±10%,pHi=6.18±0.08/6.66±0.03,P<0.05,C与IP相比]。两种剂量的格列本脲均完全消除了IP的ATP节省效应。高剂量完全消除了pHi的保留(G6+IP=6.33±0.06),而低剂量仅显示部分效应(G3+IP=6.48±0.03)。格列本脲对无IP组的心肌代谢没有不利影响。格列本脲使缺血5分钟后心内膜下和心外膜下的RH均减弱30%。
阻断KATP消除了对心肌代谢的预处理效应,并部分减弱了猪缺血后反应性充血。这些结果表明,KATP激活可能参与了这些现象的机制,反应性充血不足以诱导IP保护。